HIGHLIGHT
Pontevia

Pontevia

galcanezumab

Manufacturer:

Eli Lilly

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Galcanezumab
Indications/Uses
Migraine prophylaxis in adults who have at least 4 migraine days mthly.
Dosage/Direction for Use
Initially 240 mg SC inj as loading dose then 120 mg SC inj once mthly.
Contraindications
Special Precautions
Discontinue use if serious hypersensitivity reaction occurs. Not to be inj in tender, bruised, red or hardened skin. Immunogenicity. May affect ability to drive & use machines. Pregnancy & lactation. Childn 6-18 yr.
Adverse Reactions
Inj site reactions eg, pain, erythema, pruritus.
MIMS Class
Antimigraine Preparations
ATC Classification
N02CD02 - galcanezumab ; Belongs to the class of calcitonin gene-related peptide (CGRP) antagonists preparations. Used to relieve migraine.
Presentation/Packing
Form
Pontevia soln for inj 120 mg/mL
Packing/Price
1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in